Black Rock Inc. Uro Gen Pharma Ltd. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding URGN
# of Institutions
150Shares Held
43MCall Options Held
116KPut Options Held
42.1K-
Ubs Asset Management Americas Inc Chicago, IL4.36MShares$77.4 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY3.83MShares$68.1 Million0.69% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.21MShares$56.9 Million0.74% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$40.9 Million0.17% of portfolio
-
Vestal Point Capital, LP New York, NY2.15MShares$38.2 Million1.7% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $404M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...